Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timonen

Showing results (751-760 of 796) with videos related to

Pageof 80
Sort By:
Environmental Health Perspectives|January 24, 2009
Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart diseaseJeroen J de Hartog, Timo Lanki, Kirsi L Timonen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Molecular Pharmaceutics|August 14, 2020
Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to <i>In Vitro</i> AssessmentJelena Matović, Juulia Järvinen, Helena C Bland, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 23, 2012
Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiencesSauli Savolainen, Mika Kortesniemi, Marjut Timonen, et al.
The Science of the Total Environment|June 9, 2022
Black carbon toxicity dependence on particle coating: Measurements with a novel cell exposure methodHenri Hakkarainen, Laura Salo, Santtu Mikkonen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Traffic is a major source of atmospheric nanocluster aerosolTopi Rönkkö, Heino Kuuluvainen, Panu Karjalainen, et al.
Nature|June 27, 2018
Multifunctional ferrofluid-infused surfaces with reconfigurable multiscale topographyWendong Wang, Jaakko V I Timonen, Andreas Carlson, et al.
The American Journal of Clinical Nutrition|April 2, 2020
Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization studySaranya Palaniswamy, Dipender Gill, N Maneka De Silva, et al.
Environmental Pollution (Barking, Essex : 1987)|February 13, 2025
Importance of sub-23 nm particles in traffic environments: Particle number emission factors and extrathoracic deposition dosesHenna Lintusaari, Teemu Lepistö, Sanna Saarikoski, et al.
Pageof 80

Showing results (751-760 of 796) with videos related to

Sort By:
Pageof 80
Environmental Health Perspectives|January 24, 2009
Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart diseaseJeroen J de Hartog, Timo Lanki, Kirsi L Timonen, et al.
European Journal of Haematology|February 14, 2004
Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycleT Ruutu, E Koivunen, T Nousiainen, et al.
Molecular Pharmaceutics|August 14, 2020
Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to <i>In Vitro</i> AssessmentJelena Matović, Juulia Järvinen, Helena C Bland, et al.
Leukemia|July 17, 1998
Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia GroupE Elonen, A Almqvist, A Hänninen, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 23, 2012
Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiencesSauli Savolainen, Mika Kortesniemi, Marjut Timonen, et al.
The Science of the Total Environment|June 9, 2022
Black carbon toxicity dependence on particle coating: Measurements with a novel cell exposure methodHenri Hakkarainen, Laura Salo, Santtu Mikkonen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2017
Traffic is a major source of atmospheric nanocluster aerosolTopi Rönkkö, Heino Kuuluvainen, Panu Karjalainen, et al.
Nature|June 27, 2018
Multifunctional ferrofluid-infused surfaces with reconfigurable multiscale topographyWendong Wang, Jaakko V I Timonen, Andreas Carlson, et al.
The American Journal of Clinical Nutrition|April 2, 2020
Could vitamin D reduce obesity-associated inflammation? Observational and Mendelian randomization studySaranya Palaniswamy, Dipender Gill, N Maneka De Silva, et al.
Environmental Pollution (Barking, Essex : 1987)|February 13, 2025
Importance of sub-23 nm particles in traffic environments: Particle number emission factors and extrathoracic deposition dosesHenna Lintusaari, Teemu Lepistö, Sanna Saarikoski, et al.
Pageof 80